2022年版《国家医保药品目录》药品收录情况简析  

Drugs Included in the National Medical Insurance Drug Catalogue(2022 Edition)

作　　者：韩伟迪 朱昱 HAN Wei-di;ZHU Yu(General Hospital of Northern Theater Command,Shenyang 110016,China)

机构地区：[1]北部战区总医院,辽宁沈阳110016

出　　处：《解放军药学学报》2024年第2期160-163,共4页Pharmaceutical Journal of Chinese People's Liberation Army

摘　　要：目的对比2022年版与2000-2021年版《国家基本医疗保险、工伤保险和生育保险药品目录》(简称《医保药品目录》)收录的中西药物情况,分析变化结果,以期为《医保药品目录》的制定和完善提供参考。方法采用描述性分析方法,对比2022年版及2000-2021年版《医保药品目录》收录的西药、中成药、协议期内谈判药品的数量,以及儿童专用药品收录及构成情况的差异。结果《医保药品目录》2022年版共收录2967种药品,其中西药占53.5%,中成药占46.5%;新增了20种西药,22个儿童用药和108种谈判药品,减少了1种西药和1种中成药。同时,西药和中药的限制条件也发生了变化。结论《医保药品目录》每年平均新增或移出药品600多种,医保药品目录的调整速度加快,可以扩大患者的治疗选择范围,优化药物使用,并提供更合理、有效和经济的药物治疗指导。Objective To compare the Western and traditional Chinese medicines included in the National Medical Insurance Drug Catalogue(2022 Edition)and the Catalogue(2000-2021 Edition),and to analyze the difference in order to provide reference for future revisions.Methods Descriptive analysis was used to compare the amounts and composition of Western medicines,traditional Chinese medicines and some negotiating medicines during the term of the agreement,and identify the difference in pediatric drugs included in the National Medical Insurance Drug Catalogue(2022 Edition)and in the Catalogue(2000-2021 Edition).Results A total of 2967 drugs were included in the National Medical Insurance Drug Catalogue(2022 Edition),53.5%of which were Western medicines,and the rest were Chinese patent medicines.Compared with the Catalogue(2000-2021 Edition),20 types of new Western medicines,22 types of pediatric medicines and 108 types of negotiating medicines were added to the Catalogue(2022 Edition),while 1 type of Western medicine and one type of Chinese patent medicine were removed.At the same time,the restrictions on Western medicines and Chinese medicines changed.Conclusion The revision of the medical insurance drug catalogue has accelerated,and more than 600 drugs have been added to or removed from the catalogue on average every year,which can help bring more options for patients,optimize the use of drugs,and provide more standard,effective and economical tips for medication.

关 键 词：国家基本医疗保险工伤保险和生育保险药品目录 医保药品 国家谈判药品 

分 类 号：R954[医药卫生—药学]